TrimRx's Blog
Ozempic Prediabetes — FDA Status & Real-World Use
Ozempic isn’t FDA-approved for prediabetes, but off-label use is common. Here’s what the evidence shows about efficacy, safety, and alternatives.
Ozempic Sleep Apnea — Does Semaglutide Improve Breathing?
Semaglutide reduces obstructive sleep apnea severity by 20–30 events per hour through weight loss and airway tissue reduction — clinical evidence and
Ozempic Heart Disease — Protection or Risk? | TrimrX Blog
Ozempic reduces major cardiovascular events by 20% in high-risk patients, but proper monitoring matters. Here’s what the SELECT trial actually shows.
Ozempic NAFLD — What the Clinical Evidence Shows
Ozempic (semaglutide) showed 59% NASH resolution versus 17% placebo in NEJM-published trials — liver fat reduction extends beyond weight loss alone.
Ozempic Insulin Resistance — How GLP-1 Therapy Works
Ozempic improves insulin sensitivity through GLP-1 receptor activation, reducing hepatic glucose output and enhancing peripheral glucose uptake in muscle
Ozempic Cholesterol — Does Semaglutide Lower LDL Levels?
Ozempic (semaglutide) reduces LDL cholesterol by 3–7% and triglycerides by 12–25% through enhanced incretin signaling and reduced hepatic lipid production.
Ozempic Fatty Liver — How Semaglutide Reverses NAFLD
Semaglutide reduces liver fat by up to 40% in NAFLD patients — through mechanisms beyond weight loss alone. Here’s what the clinical evidence shows.
Ozempic Maintenance Dose — What Happens After Weight Loss
The Ozempic maintenance dose typically ranges from 0.5mg to 1.0mg weekly to sustain weight loss and glycemic control after initial titration completes.
Ozempic Thyroid Medication — Safety, Interactions & Risks
Ozempic doesn’t directly treat thyroid conditions but carries specific thyroid-related risks including rare medullary thyroid carcinoma warnings requiring
